Jodi Kantor, Krys Boyd to headline Jamison Lecture | TWU - Texas Woman's University
2025-04-01 • Google News
Krystal Biotech Inc (KRYS)
US$ 165.69-2.47%
Price Chart
Key Statistics
Market Cap
$ 3.8B
P/E Ratio
31.55
Revenue (TTM)
$ 333.45M
Volume
253.27K
52W High
$ 219.34
52W Low
$ 127.40
Dividend Yield
0.00%
Beta
0.78
Technicals
50-Day MA
165.7947
200-Day MA
173.521
52 Week High
219.34
52 Week Low
127.4
About KRYS
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United S.
Employees
275
Headquarters
Pittsburgh, PA
CEO
Mr. Krish S. Krishnan M.B.A., M.S.
Latest News
Notable Quotable: Krys Holmes, Montana Arts Council - National Endowment for the Arts (.gov)
2025-01-23 • Google News
Krystal Biotech (KRYS) Price Target Lowered by Citigroup | KRYS Stock News - GuruFocus
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg